JP2003527109A5 - - Google Patents

Download PDF

Info

Publication number
JP2003527109A5
JP2003527109A5 JP2001561057A JP2001561057A JP2003527109A5 JP 2003527109 A5 JP2003527109 A5 JP 2003527109A5 JP 2001561057 A JP2001561057 A JP 2001561057A JP 2001561057 A JP2001561057 A JP 2001561057A JP 2003527109 A5 JP2003527109 A5 JP 2003527109A5
Authority
JP
Japan
Prior art keywords
cyr61
antibody
fragment
seq
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001561057A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003527109A (ja
Filing date
Publication date
Priority claimed from US09/495,448 external-priority patent/US6790606B1/en
Application filed filed Critical
Priority claimed from PCT/US2001/003267 external-priority patent/WO2001055210A2/en
Publication of JP2003527109A publication Critical patent/JP2003527109A/ja
Publication of JP2003527109A5 publication Critical patent/JP2003527109A5/ja
Pending legal-status Critical Current

Links

JP2001561057A 2000-01-31 2001-01-31 ヒトｃｙｒ６１ Pending JP2003527109A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US09/495,448 US6790606B1 (en) 1996-03-15 2000-01-31 Extracellular matrix signaling molecules
US09/495,448 2000-01-31
US20436400P 2000-05-15 2000-05-15
US60/204,364 2000-05-15
US23870500P 2000-10-06 2000-10-06
US60/238,705 2000-10-06
PCT/US2001/003267 WO2001055210A2 (en) 2000-01-31 2001-01-31 Human cyr61

Publications (2)

Publication Number Publication Date
JP2003527109A JP2003527109A (ja) 2003-09-16
JP2003527109A5 true JP2003527109A5 (https=) 2008-03-13

Family

ID=27394650

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001561057A Pending JP2003527109A (ja) 2000-01-31 2001-01-31 ヒトｃｙｒ６１

Country Status (11)

Country Link
EP (1) EP1254174B1 (https=)
JP (1) JP2003527109A (https=)
KR (1) KR100829842B1 (https=)
CN (1) CN1447819B (https=)
AT (1) ATE360643T1 (https=)
AU (2) AU2001234721B8 (https=)
CA (1) CA2398660A1 (https=)
DE (1) DE60128066T2 (https=)
HK (1) HK1047945B (https=)
IL (3) IL150885A0 (https=)
WO (1) WO2001055210A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1608970A4 (en) * 2003-03-31 2006-06-14 Munin Corp CCN3 COMPOSITIONS AND METHODS
JP2004315480A (ja) * 2003-04-21 2004-11-11 Yoshiyuki Kakehi 前立腺疾患治療用医薬組成物
CN1835763B (zh) * 2003-06-20 2011-04-20 妙甯公司 Ccn1组合物和方法
US20050177885A1 (en) * 2004-02-09 2005-08-11 Lau Lester F. CCN1 transgenic animals
EP1838340B1 (en) 2004-12-22 2018-04-04 Cleveland Clinic Foundation Flagellin related polypeptides and uses thereof
JP5153324B2 (ja) * 2005-03-14 2013-02-27 生化学工業株式会社 硬組織形成促進剤
WO2008027288A2 (en) 2006-08-30 2008-03-06 The Trustees Of Columbia University In The City Of New York Treatment for craniosynostosis by growth factor delivery
US8188220B2 (en) * 2006-12-06 2012-05-29 Sanford-Burnham Medical Research Institute Methods and compositions related to targeting wounds, regenerating tissue, and tumors
EP2320948B1 (en) 2008-08-01 2013-03-06 Cleveland Biolabs, Inc. Methods for treating reperfusion injuries
CN101747435B (zh) * 2008-12-18 2013-06-19 上海市免疫学研究所 一种中和cyr61的单克隆抗体(杂交瘤)及其应用
TW201102086A (en) 2009-06-04 2011-01-16 Hoffmann La Roche Antibodies against human CCN1 and uses thereof
KR101187814B1 (ko) * 2010-03-22 2012-10-08 광주과학기술원 심부전 예방 또는 치료용 약제학적 조성물 및 심부전 예방 또는 치료제의 스크리닝 방법
WO2012097012A1 (en) 2011-01-10 2012-07-19 Cleveland Biolabs, Inc. Use of toll-like receptor agonist for treating cancer
US10202426B2 (en) 2014-07-30 2019-02-12 Genome Protection, Inc. Flagellin compositions and uses
US10183056B2 (en) 2014-10-16 2019-01-22 Cleveland Biolabs, Inc. Methods and compositions for the treatment of radiation-related disorders
CN108840920B (zh) * 2018-06-19 2021-09-28 中山大学孙逸仙纪念医院 一种人CYR61蛋白Ser167位点磷酸化抗原、抗体及其制备方法和应用
CN111939272B (zh) * 2020-08-21 2023-02-24 上海交通大学医学院附属第九人民医院 Ccn1的用途
CN115058388A (zh) * 2022-03-14 2022-09-16 福建医科大学附属协和医院 间充质干细胞创面修复优势功能亚群及其鉴定和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0888452T3 (da) * 1996-03-15 2004-06-14 Munin Corp Human CYR61, et ekstracellulært matrix-signalmolekyle

Similar Documents

Publication Publication Date Title
JP2003527109A5 (https=)
ES2372282T3 (es) Método para detectar probnp con un anticuerpo monoclonal que fija los aminoácidos 38-43.
JP2001511347A5 (https=)
US20090094704A1 (en) Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
US20150111250A1 (en) Methods and compositions for modulating tumor cell activity
JP2004512022A5 (https=)
EP2853898A1 (en) Analysis of myostatin in serum
WO2003093317A1 (en) Antibody to human insulin-like growth factor
JP2005505757A (ja) 結合組織増殖因子の分析方法
KR20160114088A (ko) 진단을 위한 세포 표면 전립선암 항원
JP2004536831A (ja) 副甲状腺ホルモン抗体および関連した方法
JP2004501605A5 (https=)
CA2635849A1 (en) An antibody against periostin, and a pharmaceutical composition comprising it for preventing or treating a disease in which periostin is involved
Borsi et al. Preparation of phage antibodies to the ED-A domain of human fibronectin
US8753632B2 (en) Antibodies to modified human IGF-1/E peptides
CN114174341A (zh) 抗丝氨酸蛋白酶抑制剂kazal(spik)抗体、免疫缀合物和使用方法
JP2008515388A5 (https=)
Campa et al. Design of a novel small peptide targeted against a tumor-specific receptor
JP2003510078A5 (https=)
JP2021518748A (ja) カルシトニン遺伝子関連ペプチド（ｃｇｒｐ）アンタゴニスト抗体
JPH08502414A (ja) ｐ５３蛋白断片とその疾患の検出およびモニタリングへの利用
JP5028269B2 (ja) 生理活性インタクト副甲状腺ホルモン（ｐｔｈ）１−８４に対する選択的結合特異性を有する抗体および同抗体を作製するためのペプチド抗原
JP2005522228A5 (https=)
JP3920556B2 (ja) 短縮型ミッドカイン（ｔＭＫ）タンパク質特異的モノクローナル抗体及びその用途
JP2003510071A5 (https=)